Best Wishes to Our Departing Editor-in-Chief
Introduction and Summary of the Workshop “Drug Research Support: Selection and Early Development”
Strategic Importance of Research Support through Pathology
Practical Aspects of Discovery Pathology
Laser Technologies in Toxicopathology
Toxicogenomics, Drug Discovery, and the Pathologist
SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats—Histopathologic, Electron Microscopic, and Immunohistochemical Studies
Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity
Immune Responses: Adverse Versus Non-Adverse Effects
Endocrine Active Agents: Implications of Adverse and Non-Adverse Changes
Recognition of Adverse and Nonadverse Effects in Toxicity Studies
The North American Control Animal Database: A Resource Based on Standardized Nomenclature and Diagnostic Criteria
The Value of Historical Control Data—Scientific Advantages for Pathologists, Industry and Agencies
Quality Review Procedures Necessary for Rodent Pathology Databases and Toxicogenomic Studies: The National Toxicology Program Experience
Qualitative and Quantitative Analysis of Nonneoplastic Lesions in Toxicology Studies
Quantitation of the Cancer Process in C57BL/6J, B6C3F1 and C3H/HeJ Mice
The Use of Quantitative Histological and Molecular Data for Risk Assessment and Biologically Based Model Development
Quantitation of Molecular Endpoints for the Dose-Response Component of Cancer Risk Assessment
Current Methods for Assessing Safety of Genetically Modified Crops as Exemplified by Data on Roundup Ready 1 Soybeans
Safety Assessment and Public Concerns for Genetically Modified Food Products: The Japanese Experience
Safety Assessment and Public Concern for Genetically Modified Food Products: The European View
Safety Assessments and Public Concern for Genetically Modified Food Products: The American View
Application of Genetically Altered Models as Replacement for the Lifetime Mouse Bioassay in Pharmaceutical Development
The Tg rasH2 Mouse in Cancer Hazard Identification
The Trp53 Hemizygous Mouse in Pharmaceutical Development: Points to Consider for Pathologists
Alternatives Models in Carcinogenicity Testing—A European Perspective
Toxicologic Pathology in the New Millennium 1